KURNIAWAN, J.; HANDAYU, A. D.; APRILICIA, G.; BAHRI, D. R.; HASAN, I. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Acta Medica Indonesiana, [S. l.], v. 56, n. 4, p. 451, 2025. Disponível em: http://www.actamedindones.org/index.php/ijim/article/view/2625. Acesso em: 23 dec. 2025.